457 related articles for article (PubMed ID: 36926335)
1. Quantitative and causal analysis for inflammatory genes and the risk of Parkinson's disease.
Yi M; Li J; Jian S; Li B; Huang Z; Shu L; Zhang Y
Front Immunol; 2023; 14():1119315. PubMed ID: 36926335
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].
Durić G; Svetel M; Nikolaevic SI; Dragadević N; Gavrilović J; Kostić VS
Vojnosanit Pregl; 2007 Jan; 64(1):25-30. PubMed ID: 17304721
[TBL] [Abstract][Full Text] [Related]
3. Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.
Belin AC; Ran C; Anvret A; Paddock S; Westerlund M; Håkansson A; Nissbrandt H; Söderkvist P; Dizdar N; Ahmadi A; Anvret M; Willows T; Sydow O; Galter D
Neurosci Lett; 2012 Jul; 522(1):30-5. PubMed ID: 22704918
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C/T, and ABCB1 3435C/T polymorphisms with the risk of Parkinson's disease: A meta-analysis.
Huang H; Peng C; Liu Y; Liu X; Chen Q; Huang Z
Medicine (Baltimore); 2016 Oct; 95(40):e4982. PubMed ID: 27749554
[TBL] [Abstract][Full Text] [Related]
5. Genomic and pharmacogenomic biomarkers of Parkinson's disease.
Alonso-Navarro H; Jimenez-Jimenez FJ; Garcia-Martin E; Agundez JA
Curr Drug Metab; 2014 Feb; 15(2):129-81. PubMed ID: 24694231
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between BST1 polymorphisms and sporadic Parkinson's disease in a Japanese population.
Miyake Y; Tanaka K; Fukushima W; Kiyohara C; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
J Neurol Sci; 2012 Dec; 323(1-2):162-6. PubMed ID: 23026536
[TBL] [Abstract][Full Text] [Related]
7. Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson's disease: a meta-analysis.
Wang S; Xu YF; Ding XY; Liu ZR; Ding Y; Jin B; Wang S; Ding MP
Neurosci Lett; 2015 Jul; 599():120-4. PubMed ID: 25986899
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort.
Pascale E; Passarelli E; Purcaro C; Vestri AR; Fakeri A; Guglielmi R; Passarelli F; Meco G
Acta Neurol Scand; 2011 Sep; 124(3):176-81. PubMed ID: 20880267
[TBL] [Abstract][Full Text] [Related]
9. BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson's disease in a Taiwanese population.
Chen ML; Lin CH; Lee MJ; Wu RM
Parkinsonism Relat Disord; 2014 Mar; 20(3):280-3. PubMed ID: 24342025
[TBL] [Abstract][Full Text] [Related]
10. Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.
Singh M; Khanna VK; Shukla R; Parmar D
Dis Markers; 2010; 28(2):87-93. PubMed ID: 20364044
[TBL] [Abstract][Full Text] [Related]
11. A Mendelian randomization study investigating the causal role of inflammation on Parkinson's disease.
Bottigliengo D; Foco L; Seibler P; Klein C; König IR; Del Greco M F
Brain; 2022 Oct; 145(10):3444-3453. PubMed ID: 35656776
[TBL] [Abstract][Full Text] [Related]
12. Leads from xenobiotic metabolism genes for Parkinson's disease among north Indians.
Punia S; Das M; Behari M; Dihana M; Govindappa ST; Muthane UB; Thelma BK; Juyal RC
Pharmacogenet Genomics; 2011 Dec; 21(12):790-7. PubMed ID: 22016051
[TBL] [Abstract][Full Text] [Related]
13. Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis.
Zintzaras E; Hadjigeorgiou GM
J Hum Genet; 2004; 49(9):474-481. PubMed ID: 15368102
[TBL] [Abstract][Full Text] [Related]
14. Role of CD36 rs1761667 AA genotype in the expression of inflammatory cytokines and Parkinson's disease progression: A case-control study in a northern Han Chinese population.
Li C; Hou B; Li X; Yang Z; Xie A
Neurosci Lett; 2022 Jul; 784():136736. PubMed ID: 35709881
[TBL] [Abstract][Full Text] [Related]
15. STK39, But Not BST1, HLA-DQB1, and SPPL2B Polymorphism, Is Associated With Han-Chinese Parkinson's Disease in Taiwan.
Chang KH; Wu YR; Chen YC; Fung HC; Lee-Chen GJ; Chen CM
Medicine (Baltimore); 2015 Oct; 94(41):e1690. PubMed ID: 26469904
[TBL] [Abstract][Full Text] [Related]
16. NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis.
Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JA
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):937-46. PubMed ID: 27216438
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between three single nucleotide polymorphisms in the PARK9, PARK15, and BST1 genes and Parkinson's disease in the northern Han Chinese population.
Zhu LH; Luo XG; Zhou YS; Li FR; Yang YC; Ren Y; Pang H
Chin Med J (Engl); 2012 Feb; 125(4):588-92. PubMed ID: 22490479
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases.
Wingo TS; Rosen A; Cutler DJ; Lah JJ; Levey AI
Neurobiol Aging; 2012 Jan; 33(1):204.e13-5. PubMed ID: 20947215
[TBL] [Abstract][Full Text] [Related]
19. Exonic sequencing revealed no causative mutation in the BST1 gene in patients with Parkinson's disease.
Wang C; Feng X; Xie S; Gu Z; Chan P
Neurobiol Aging; 2013 Nov; 34(11):2695.e9-2695.e10. PubMed ID: 23827523
[TBL] [Abstract][Full Text] [Related]
20. The single nucleotide polymorphism Rs12817488 is associated with Parkinson's disease in the Chinese population.
Yu RL; Guo JF; Wang YQ; Liu ZH; Sun ZF; Su L; Zhang Y; Yan XX; Tang BS
J Clin Neurosci; 2015 Jun; 22(6):1002-4. PubMed ID: 25818163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
